Testosterone Heart Attack

Published on February 21, 2014 by Sandy Liebhard

Text-Size:A A A+

While certain “Low T” prescription treatment therapies like AndroGel have been suggested to increase the risk for a testosterone heart attack or stroke, the U.S. Food and Drug Administration (FDA) maintains that no connection has been confirmed.

The attorneys at Bernstein Liebhard LLP are however, actively investigating potential testosterone lawsuits from men who may have experienced a cardiovascular injury stemming from AndroGel or another medication. According to a public health alert issued January 31st, 2014 by the U.S. Food and Drug Administration (FDA), sudden cardiac death, cardiovascular arrest and other heart problems may be associated with a range of prescriptions designed to raise testosterone levels in men with low levels of the hormone. If you took a Low T testosterone therapy treatment and suffered one or more of these life-threatening side effects, it is imperative that you contact our Firm today to receive a free and confidential evaluation of your case.

In January 2014, the FDA issued a Drug Safety Communication in which they vowed to conduct a safety review of several “Low” testosterone therapy treatments on today’s market. The following medications have been allegedly associated with testosterone stroke and heart attacks:

  • AndroGel
  • Axiron
  • Androderm
  • Depo-Testosterone
  • Striant
  • Bio-T-Gel
  • Delatestryl
  • Fortesta
  • Testopel

The agency’s public health alert followed a number of studies that lent evidence to the possibility that Low T medications may pose serious dangers to patients.

Testosterone Heart Attack and Stroke Risks

Since last year, a number of studies have raised awareness on potential side effects of certain “Low T” therapies. The attorneys at Bernstein Liebhard LLP are actively pursuing testosterone stroke and heart attack lawsuits on behalf of men who may have been injured by AndroGel or another medication.

According to research published in November 2013, the Journal of the American Medical Association released results of a study that found an increased risk of testosterone heart attack, stroke and even death in older men with pre-existing heart problems.

The association between Low T treatments and the risk for testosterone heart attacks again made headlines in January 2014, when the medical journal, PLoS One found that men younger than 65 with pre-existing heart issues and all older men may be at a doubled risk for heart attack than those not taking Low T treatments.

Later that month, the FDA’s public health warning highlighted its commitment to investigating these findings, and may have even prompted the filing of AndroGel lawsuits. In the weeks that followed the agency’s alert, court documents indicate that a number of claims were filed in the U.S. District Court, Northern District of Illinois on behalf of individuals who say that some drug manufacturers failed to warn about their products’ potential to cause side effects. A lawsuit filed on February 4th further alleges that AndroGel was promoted to men with normal levels of testosterone, and for symptoms normally associated with aging. These may include fatigue and low libido. Despite AndroGel and other medications’ FDA approval in treating low testosterone in conjunction with another medical condition, claimants say they have been marketed to men with normal levels of the hormone.

File a Testosterone Stroke or Heart Attack Lawsuit

Men who may have experienced a testosterone stroke or heart attack after taking AndroGel or another medication may be eligible to file a lawsuit with our Firm. Potential claimants may be eligible to receive compensation for additional medical expenses, lost wages and other damages allegedly caused by their situation. Call us now at .